Curiteva Porous PEEK Cervical Interbody Fusion System— 510(k) K254061

Name: FDA 510(k) clearance K254061
Creator: U.S. Food and Drug Administration
Published: 2026-01-15

Substantially Equivalent

Curiteva, Inc.

FDA 510(k) clearance K254061 for Curiteva Porous PEEK Cervical Interbody Fusion System, Substantially Equivalent on 2026-01-15. Applicant: Curiteva, Inc.. Device class: 2.

Clearance details

Applicant: Curiteva, Inc.
Product code: Code ODP
Device class: Class 2
Regulation: 21 CFR 888.3080
Advisory panel: Orthopedic
Date received: 2025-12-17
Decision date: 2026-01-15
Decision: Substantially Equivalent
Clearance type: Special
Location: Tanner, AL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code ODP

view all

K262595 — VariLift-C Cervical Interbody Fusion System2026-08-26
K262489 — BluEX Cervical Expandable Cage System2026-08-18
K253041 — 3d Cage Cervical2026-07-23
K262061 — Tritanium® C Anterior Cervical Cage +16 more2026-07-17
K254130 — C.A. Medical Interbody Fusion System2026-07-08

More clearances from Curiteva, Inc.

view all

K252205 — Curiteva Porous PEEK Cervical Interbody System +3 more2026-01-16
K250845 — Curiteva Porous PEEK Standalone ALIF System2025-06-18
K243137 — Curiteva Porous PEEK Laminoplasty System2024-10-28
K233360 — Curiteva Thoracolumbar Plate System2024-02-29
K233744 — Curiteva Porous PEEK Lumbar Interbody Fusion System2024-01-18

Adverse events under product code ODP

product code ODP

Injury: 310
Total: 310

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.